- Adams, E.K.; Miller, V.P.; Ernst, C.; Nishimura, B.K.; Melvin, C.; and Merritt, R. Neonatal health care costs related to smoking during pregnancy. Health Economics 11:193–206, 2002.
- Belluzzi, J.D.; Wang, R.; and Leslie, F.M. Acetaldehyde enhances acquisition of nicotine self-administration in adolescent rats. Neuropsychopharmacol 30:705–712, 2005.
- Benowitz, N.L. Pharmacology of nicotine: Addiction and therapeutics. Ann Rev Pharmacol Toxicol 36:597–613, 1996.
- Breslau, N., and Johnson, E.O. Predicting smoking cessation and major depression in nicotine-dependent smokers. Am J Public Health 90(7):1122–1127, 2000.
- Buka, S.L.; Shenassa, E.D.; and Niaura, R. Elevated risk of tobacco dependence among offspring of mothers who smoked during pregnancy: A 30-year prospective study. Am J Psychiatry 160:1978–1984, 2003.
- Covey, L.S.; Glassman, A.H.; and Stetner, F. Major depression following smoking cessation. Am J Psychiatry 154:263–265, 1997.
- Dervaux, A., and Laqueille, X. Smoking and schizophrenia: Epidemiological and clinical features. Encephale 34(3):299–305, 2008.
- Ernst, M.; Moolchan, E.T.; and Robinson, M.L. Behavioral and neural consequences of prenatal exposure to nicotine. J Am Acad Child Adolesc Psychiatry 40:630–641, 2001.
- Fowler, J.S.; Volkow, N.D.; Wang, G.J.; Pappas, N.; Logan, J.; MacGregor, R.; Alexoff, D.; Shea, C.; Schlyer, D.; Wolf, A.P.; Warner, D.; Zezulkova, I.; and Cilento, R. Inhibition of monoamine oxidase B in the brains of smokers. Nature 22:733–736, 1996.
- Hatsukami, D.K.; Lemmonds, C.; Zhang, Y.; Murphy, S.E.; Le, C.; Carmella, S.G.; and Hecht, S.S. Evaluation of carcinogen exposure in people who used "reduced exposure" tobacco products. J Natl Cancer Inst 96:844–852, 2004.
- Henningfield, J.E. Nicotine medications for smoking cessation. New Engl J Med 333:1196–1203, 1995.
- Johnston, L.D.; O’Malley, P.M.; Bachman, J.G.; and Schulenberg, J.E. Monitoring the Future National Results on Adolescent Drug Use: Overview of Key Findings, 2011. NIH Pub. No. 11–6418. Bethesda, MD: National Institute on Drug Abuse, 2011. Available at: www.monitoringthefuture.org.
- Ilomäki, R., et al. Temporal association of onset of daily smoking with adolescent substance use and psychiatric morbidity. Eur Psychiatry 23(2):85–91, 2008.
- John, U.; Meyer, C.; Rumpf, H.J.; and Hapke, U. Smoking, nicotine dependence and psychiatric comorbidity: A population-based study including smoking cessation after three years. Drug Alcohol Depend 76:287–295, 2004.
- Kalman, D.; Morissette, S.B.; and George, T.P. Comorbidity of smoking in patients with psychiatric and substance use disorders. Am J Addict 14(2):106–123, 2005.
- Kollins, S.H.; McClernon, F.J.; and Fuemmeler, B.F. Association between smoking and attention-deficit/hyperactivity disorder symptoms in a population-based sample of young adults. Arch Gen Psychiatry 62:1142–1147, 2005.
- Levin, E.D.; Rezvani, A.H.; Montoya, D.; Rose, J.E.; and Swartzwelder, H.S. Adolescent-onset nicotine self-administration modeled in female rats. Psychopharmacol 169:141–149, 2003.
- Morissette, S.B.; Tull, M.T.; Gulliver, S.B.; Kamholz, B.W.; and Zimering, R.T. Anxiety, anxiety disorders, tobacco use, and nicotine: A critical review of interrelationships. Psychol Bull 133(2):245–272, 2007.
- Perkins, K.A.; Donny, E.; and Caggiula, A.R. Sex differences in nicotine effects and self–administration: Review of human and animal evidence. Nic and Tobacco Res 1:301–315, 1999.
- Saccone, S.F., et al. Cholinergic nicotinic receptor genes implicated in a nicotine dependence association study targeting 348 candidate genes with 3713 SNPs. Hum Mol Genet 16(1):36–49, 2007.
- Substance Abuse and Mental Health Services Administration. Results from the 2010 National Survey on Drug Use and Health: Summary of National Findings. NSDUH Series H-41, HHS Publication No. SMA 11-4658. Rockville, MD: Substance Abuse and Mental Health Services Administration, 2011. Available at http://oas.samhsa.gov/NSDUH/2k10NSDUH/2k10Results.htm.
- Thorgeirsson, T.E., et al. A variant associated with nicotine dependence, lung cancer and peripheral arterial disease. Nature 452(7187):638–642, 2008.
- U.S. Department of Health and Human Services. Reducing Tobacco Use: A Report of the Surgeon General. Atlanta: Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health, 2000. Available at: http://www.cdc.gov/tobacco/data_statistics/sgr/index.htm.
- U.S. Department of Health and Human Services. The Health Benefits of Smoking Cessation: A Report of the Surgeon General. Atlanta: Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health, 1990. Available at: http://www.cdc.gov/tobacco/data_statistics/sgr/index.htm.
- U.S. Department of Health and Human Services. The Health Consequences of Smoking: A Report of the Surgeon General. Atlanta: Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health, 2004. Available at: http://www.cdc.gov/tobacco/data_statistics/sgr/sgr_2004/index.htm.
Cite this article
NIDA. (2012, July 1). Tobacco/Nicotine. Retrieved from https://www.drugabuse.gov/publications/research-reports/tobacconicotine
This series of reports simplifies the science of research findings for the educated lay public, legislators, educational groups, and practitioners. The series reports on research findings of national interest.